Park Ha Biological Technology Co., Ltd. - Form 6-K Filing on Securities Purchase Agreement

Park Ha Biological Technology Co., Ltd. has entered into securities purchase agreements (SPA) with investors for the offering and sale of Class A ordinary shares and pre-funded warrants. The offering, conducted on a "best-efforts" basis, involved the sale of 1,133,332 Class A ordinary shares and pre-funded warrants to purchase up to 200,000 Class A ordinary shares at a combined price of $1.50 per share and warrant. The company raised approximately $2.0 million in gross proceeds before fees and expenses, intending to use the net proceeds for working capital and general corporate purposes. The offering closed on June 15, 2026. The SPA includes customary representations, warranties, covenants, and closing conditions. The securities were offered under a shelf registration statement on Form F-3. Additionally, the company entered into a placement agency agreement (PAA) with D. Boral Capital LLC, compensating the agent with an 8.0% success fee and non-accountable expenses. The company also issued press releases on June 12 and June 15, 2026, announcing the pricing and closing of the offering, respectively.